Nanotechnology's Impact on Ocular Drug Delivery: A Meta-analysis-based Examination

9Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

There are several challenges in ophthalmology due to the complex physiological structure of eye. In recent years, the field of ophthalmology has witnessed a surge in research exploring the potential of nanomaterials. Nanomaterials are preferred for their biocompatibility and soluble nature, making them ideal for ophthalmic use. These properties aim to enhance the bioavailability of drugs in this system. We pooled data from various studies using nanotechnology-based formulations to evaluate their influence on ocular drug bioavailability, focusing on AUC as a key metric. A total of 21 studies conducted in different regions of the world were investigated. The investigation determined that nanotechnology-based formulations has a significant potential for improving ocular medications bioavailability. The meta-analysis results indicate that drugs coated with chitosan, chitosan-coated polylactic acid, and lipid carriers exhibit more significant improvement than the drugs without nano carriers.

Cite

CITATION STYLE

APA

Santhosh Kumar, Y., Gurudeva, C., Sridevi, G., Langeswaran, K., & Gowtham Kumar, S. (2024). Nanotechnology’s Impact on Ocular Drug Delivery: A Meta-analysis-based Examination. Nano Biomedicine and Engineering, 16(3), 510–519. https://doi.org/10.26599/NBE.2024.9290081

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free